Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Su Hui therapy logo — Driving advancements in vaccine development, cell therapy, a...

Su Hui therapy

Driving advancements in vaccine development, cell therapy, and mRNA drug innovation for a healthier future.

Founded 2021 Seed Total: $100.00M Biotechnology

General Information

Company Name Su Hui therapy
Founded Year 2021
Industries Biotechnology
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Su Hui therapy. To contact Su Hui therapy, visit healrna.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Su Hui therapy compare?

A PDF of Su Hui therapy and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Su Hui therapy soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Su Hui therapy

Su Hui therapy

Slogan: Driving advancements in vaccine development, cell therapy, and mRNA drug innovation for a healthier future.

Description: HealiRNA focuses on developing infectious disease vaccines, tumor vaccines, cell therapy, and protein replacement. They specialize in providing mRNA drug research and development, production, clinical trial design, and data analysis services.

Founded: 2021

Industries: Biotechnology

Last Investment: CNY100.00M Seed Round investment at 10 March 2023

Last Investment Investors: Shunwei Capital, Sino-Singapore Capital, Ming Bioventures, Sequoia Capital China, Yajie Shanghui

In summary, Su Hui therapy is a biotechnology startup founded in 2021 that is driving progress in vaccine development, cell therapy, and mRNA drug innovation. The company received a CNY100.00M Seed Round investment on 10 March 2023 from notable investors including Shunwei Capital, Sino-Singapore Capital, Ming Bioventures, Sequoia Capital China, and Yajie Shanghui, positioning it for further growth and advancement in the biotechnology industry.

Business keywords: vaccine development, mRNA drug innovation, cell therapy, infectious disease vaccines, tumor vaccines, protein replacement, mRNA drug research, clinical trial design

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round CNY100.00M 5
Shunwei Capital Sino-Singapore Capital Ming Bioventures
Shunwei Capital, Sino-Singapore Capital +3
10 Mar 2023

Su Hui therapy Alternatives & Competitors

View All Alternatives
Su Hui therapy vs
BioVaxys Technology Corp.
BioVaxys Technology Corp. Canada

Antiviral and Anticancer Vaccine Platforms Harnessing the Power of T-Cells

Post-IPO Equity
5 employees
Biopharma, Biotechnology
Su Hui therapy vs
Huasaiboman Medical Cell Biology
Huasaiboman Medical Cell Biology

Pioneering tomorrow's treatments for solid tumors and degenerative diseases through state-of-the-art...

Series A
Biotechnology, Life Sciences
Su Hui therapy vs
Drug Discovery & Development
Drug Discovery & Development United States

Strategies and technologies driving drug discovery to market.

10 employees
Biotechnology, Pharmaceutical
Also compare with: Su Hui therapy vs 星尘生物科技(上海)有限公司 星尘生物科技(上海)有限公司 View all alternatives

FAQ About Su Hui therapy

Driving advancements in vaccine development, cell therapy, and mRNA drug innovation for a healthier future.
Su Hui therapy was founded in 2021.
Su Hui therapy operates in Biotechnology. Its work centres on vaccine development, mRNA drug innovation, cell therapy and infectious disease vaccines.
Su Hui therapy has completed 1 funding round, raising a total of $100.00M. The latest funding stage is Seed.
Top alternatives and competitors to Su Hui therapy include BioVaxys Technology Corp., Huasaiboman Medical Cell Biology, Drug Discovery & Development, EMERGEX VACCINES LTD, Porton Advanced | ATMP CDMO/CRO. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Su Hui therapy and BioVaxys Technology Corp. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Su Hui therapy, https://bouncewatch.com/company/su-hui-therapy, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout